TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/12/2024
Voltar para busca
Dado oficial do USPTO
EXSCALATE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
26/12/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 42
Data de depósito
23/11/2022
Data de registro
14/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/05/2024
Última transação
26/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
09
Localização do titular
IT
Examinador
WATTS-FITZGERALD, CAITLIN
Unidade examinadora
M20
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the word "EXSCALATE" in black, to the left of which appears a red, dark red, and light red cube design outlined in black, the rear of which is a square shape while the front shape is that of an X. White indicates transparent matter and is not claimed as a feature of the mark.
Titulares e representantes
Titulares
Dompe' farmaceutici Spa
Representantes
Theodore R. Remaklus Thompson Hine LLP
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturingtrackingreportinganalyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teachingspecificallyfor granting user access to courses of instruction in the medical field; downloadable virtual screening softwarespecificallysoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesfacilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration software platforms for use in database management in the field of medicine; downloadable computer software platforms for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; downloadable artificial intelligence software for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models in the field of healthcare
Classe 42
Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; providing temporary use of onlinenon-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; design and development of virtual screening software; design and development of virtual reality software for teaching medicine
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/12/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/11/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/11/2024
FIMP
FINAL DISPOSITION PROCESSED
07/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
14/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2024
PUBO
PUBLISHED FOR OPPOSITION
27/02/2024
GPNX
NOTIFICATION PROCESSED BY IB
26/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/02/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
23/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
11/01/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/01/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
11/01/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2024
RFNT
REFUSAL PROCESSED BY IB
17/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/09/2023
RFRR
REFUSAL PROCESSED BY MPU
25/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/09/2023
CNRT
NON-FINAL ACTION WRITTEN
06/09/2023
DOCK
ASSIGNED TO EXAMINER
06/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
13/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/01/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXSCALATE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.